Tiverton Asset Management’s Q32 Bio QTTB Stock Holding History

Tiverton Asset Management’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$118K	Buy	+364	New	+$124K	﹤0.01%	627

Other funds holding QTTB

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tiverton Asset Management's QTTB Position: Q3 2019 in Review

Tiverton Asset Management opened a new position in Q32 Bio (QTTB) in Q3 2019: 364 shares worth $118K. The stake represents ﹤0.01% of the portfolio and ranks #627 among its holdings.

80 funds tracked by Wall St. Rank hold QTTB as of Q3 2019.

Tiverton Asset Management held 364 shares of Q32 Bio worth $118K as of Q3 2019.
Q32 Bio was a new Tiverton Asset Management position in Q3 2019.
Q32 Bio made up ﹤0.01% of Tiverton Asset Management's portfolio in Q3 2019, its #627 holding.
80 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.